Literature DB >> 7561429

Ophthalmoscopy for congenital hypertrophy of the retinal pigment epithelium (CHRPE) in patients with sporadic colorectal carcinoma.

A Hartvigsen1, T Myrhøj, S Bülow, K K Børme, J O Søndergaard, K Højgaard-Olsen, I Bernstein.   

Abstract

In order to investigate the frequency of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in sporadic colorectal cancer, ophthalmoscopy was carried out in 34 patients with colorectal carcinoma without known familial disposition. CHRPE is one of the most frequent extracolonic manifestations in familial adenomatous polyposis. None of the patients showed any sign of CHRPE. It is concluded that although genetic factors are presumably of importance in the development of sporadic colorectal cancer, CHRPE cannot be used as a marker for future risk of colorectal carcinoma except in polyposis families.

Entities:  

Mesh:

Year:  1995        PMID: 7561429     DOI: 10.1007/BF00298534

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  13 in total

1.  The Gardner syndrome. Significance of ocular features.

Authors:  R A Lewis; W E Crowder; L A Eierman; R L Nussbaum; R E Ferrell
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

2.  Importance of retinal pigmentation as a subclinical marker in familial adenomatous polyposis.

Authors:  S Baba; M Tsuchiya; I Watanabe; H Machida
Journal:  Dis Colon Rectum       Date:  1990-08       Impact factor: 4.585

3.  Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome.

Authors:  N P Blair; C L Trempe
Journal:  Am J Ophthalmol       Date:  1980-11       Impact factor: 5.258

4.  Mandibular osteomas in familial polyposis coli.

Authors:  S Bülow; J O Søndergaard; I Witt; E Larsen; G Tetens
Journal:  Dis Colon Rectum       Date:  1984-02       Impact factor: 4.585

5.  Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

Authors:  S Olschwang; A Tiret; P Laurent-Puig; M Muleris; R Parc; G Thomas
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

6.  A genetic study of Gardner syndrome and congenital hypertrophy of the retinal pigment epithelium.

Authors:  L A Lyons; R A Lewis; L C Strong; S Zuckerbrod; R E Ferrell
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

7.  Cancer incidence among parents of patients with colorectal cancer.

Authors:  J O Søndergaard; S Bülow; E Lynge
Journal:  Int J Cancer       Date:  1991-01-21       Impact factor: 7.396

8.  Cancer incidence among spouses of patients with colorectal cancer.

Authors:  A Mellemgaard; O M Jensen; E Lynge
Journal:  Int J Cancer       Date:  1989-08-15       Impact factor: 7.396

9.  Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome.

Authors:  E I Traboulsi; A J Krush; E J Gardner; S V Booker; G J Offerhaus; J H Yardley; S R Hamilton; G D Luk; F M Giardiello; S B Welsh
Journal:  N Engl J Med       Date:  1987-03-12       Impact factor: 91.245

10.  Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry.

Authors:  M Ponz de Leon; R Sassatelli; C Sacchetti; G Zanghieri; A Scalmati; L Roncucci
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

View more
  2 in total

1.  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Authors:  Celia S Chen; Kerry D Phillips; Scott Grist; Graeme Bennet; Jamie E Craig; James S Muecke; Graeme K Suthers
Journal:  Fam Cancer       Date:  2006-08-31       Impact factor: 2.375

2.  Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer.

Authors:  M G Dunlop; S M Farrington; V J Bubb; C Cunningham; M Wright; L J Curtis; Z A Butt; E Wright; B W Fleck; D Redhead; R Mitchell; J B Rainey; I M Macintyre; D C Carter; A H Wyllie
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.